High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial

By Pfeiffer Per  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 224-229

Informa Healthcare

Access to resources Recommend Favorite

Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer

By las Heras Manuel  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naïve Locally Advanced Upper Aerodigestive Malignancy

By Langer Corey   Duffy Karen   Horwitz Eric   Litwin Samuel   Rosvold Elizabeth   Schol Jessie   Keenan Eileen   Nicolaou Nicos   Friedman Craig   Ridge John  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 164-173

Informa Healthcare

Access to resources Recommend Favorite

High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial

By Vestermark Lene W.   Jensen Helle A.   Pfeiffer Per  

Acta Oncologica, Vol. 51, Iss. 3, 2012-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205

By Imano Motohiro   Furukawa Hiroshi   Yokokawa Masaki   Nishimura Yasumasa   Kurokawa Yukinori   Satoh Taroh   Sakai Daisuke   Yasuda Takushi   Imamoto Haruhiko   Tujinaka Toshimasa   Shimokawa Toshio   Shiozaki Hitoshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 431-435

Oxford University Press

Access to resources Recommend Favorite